TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
852,286
|
458,510
|
209,553 |
| Financial expenses |
26,409
|
140,758
|
25,885 |
| Earnings before taxes |
30,375
|
15,605
|
24,066 |
| EBITDA |
14,039
|
-13,591
|
12,310 |
| Total assets |
401,352
|
290,942
|
268,422 |
| Current assets |
399,246
|
277,480
|
266,395 |
| Current liabilities |
305,143
|
224,938
|
213,942 |
| Equity capital |
92,754
|
64,235
|
53,536 |
| - share capital |
2,026
|
1,892
|
1,950 |
| Employees (average) |
14
|
14
|
14 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
23.1%
|
22.1%
|
19.9% |
| Turnover per employee |
60,878
|
32,751
|
14,968 |
| Profit as a percentage of turnover |
3.6%
|
3.4%
|
11.5% |
| Return on assets (ROA) |
14.1%
|
53.7%
|
18.6% |
| Current ratio |
130.8%
|
123.4%
|
124.5% |
| Return on equity (ROE) |
32.7%
|
24.3%
|
45.0% |
| Change turnover |
361,241
|
255,255
|
142,465 |
| Change turnover % |
74%
|
126%
|
212% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.